Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.
Alto Dividendo
A empresa é uma grande pagadora de dividendos, com índice de distribuição mais recente de 34.38%.
Sobreavaliada
O PE mais recente da empresa é 14.25, em uma faixa percentil alta de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 239.27M ações, uma redução de 1.64% em relação ao trimestre anterior.
Mantido por Irving Kahn
O Super Investidor Irving Kahn possui 2.48M ações desta empresa.
Baixa Atividade de Mercado
A empresa tem menor interesse dos investidores, com uma taxa de giro de 20 dias de -0.41.